Oramed Pharmaceuticals
ORMP
#9089
Rank
C$0.13 B
Marketcap
$3.39
Share price
0.85%
Change (1 day)
-14.87%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2024 (TTM): C$33.14 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of C$10.2 Million, an increase over its 2022 earnings that were of -C$52.47 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$33.14 M224.8%
2023 C$10.2 M-119.45%
2022 -C$52.47 Million39.17%
2021 -C$37.7 Million73.93%
2020 -C$21.68 Million18.53%
2019 -C$18.29 Million-16.62%
2018 -C$21.93 Million38.32%
2017 -C$15.86 Million12.51%
2016 -C$14.1 Million25.01%
2015 -C$11.28 Million18.18%
2014 -C$9.54 Million39.72%
2013 -C$6.83 Million46.4%
2012 -C$4.67 Million128.32%
2011 -C$2.05 Million-51.47%
2010 -C$4.21 Million35.21%
2009 -C$3.12 Million
2007 -C$4.9 Million607.04%
2006 -C$0.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.73 Billion-2,147.42%๐Ÿ‡บ๐Ÿ‡ธ USA
C$27.12 B 76,757.93%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
C$11.37 B 32,128.38%๐Ÿ‡ซ๐Ÿ‡ท France
-C$13.91 Million-139.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-C$0.29 Billion-913.22%๐Ÿ‡บ๐Ÿ‡ธ USA